全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Peripartum Cardiomyopathy Complicated by Ventricular Tachycardia during Labor: A Case Report and Literature Review

DOI: 10.4236/ojog.2024.143034, PP. 365-380

Keywords: Peripartum Cardiomyopathy, Ventricular Tachycardia, High Risk Pregnancy, Antenatal Care, Delivery Planning

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background: Peripartum cardiomyopathy (PPCM) is a rare disease that typically affects young, healthy women. Because PPCM is associated with significant mortality, timely diagnosis and management are essential. Ventricular tachycardia (VT) is a major complication and contributor to sudden death. Available data on VT in patients with PPCM are limited. Aim: This case report demonstrates the clinical presentation, antenatal care, and management of labor and delivery in a patient with PPCM complicated by VT. Case report: 36-year old patient G4P3 presents at 27 weeks gestation to the emergency department complaining of chest tightness, palpitations, and profuse sweating. Peripartum cardiomyopathy was diagnosed after her last pregnancy a few years prior. Ventricular tachycardia was diagnosed at this visit and treated successfully. The remainder of the pregnancy was uneventful until she had another episode of ventricular tachycardia during labor. Treatment using antiarrhythmics (diltiazem, amiodarone, adenosine) highlights the importance of prompt intervention and the need for a range of therapeutic options. Results: This case demonstrated successful VT management during pregnancy and labor, emphasizing multidisciplinary collaboration, influencing maternal and fetal outcomes positively, providing insights into optimal care strategies. Conclusion: Peripartum cardiomyopathy complicated by ventricular tachycardia is a life-threatening combination. This case highlights the importance of timely diagnosis and management with combined care between cardiologists, maternal fetal medicine specialists and anesthesiologists

References

[1]  Schaufelberger, M. (2019) Cardiomyopathy and Pregnancy. Heart, 105, 1543-1551.
https://doi.org/10.1136/heartjnl-2018-313476
[2]  Lata, I., Gupta, R., Sahu, S. and Singh, H. (2009) Emergency Management of Decompensated Peripartum Cardiomyopathy. Journal of Emergencies, Trauma, and Shock, 2, 124-128.
https://doi.org/10.4103/0974-2700.50748
[3]  Sliwa, K., Hilfiker-Kleiner, D., Petrie, M.C., et al. (2010) Current State of Knowledge on Aetiology, Diagnosis, Management, and Therapy of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. European Journal of Heart Failure, 12, 767-778.
https://doi.org/10.1093/eurjhf/hfq120
[4]  Spracklen, T.F., Chakafana, G., Schwartz, P.J., Kotta, M.C., Shaboodien, G., Ntusi, N.A.B. and Sliwa, K. (2021) Genetics of Peripartum Cardiomyopathy: Current Knowledge, Future Directions and Clinical Implications. Genes (Basel), 12, Article No. 103.
https://doi.org/10.3390/genes12010103
[5]  Salam, A.M., Ahmed, M.B., Sulaiman, K., Singh, R., Alhashemi, M., Carr, A.S., Alsheikh-Ali, A.A., AlHabib, K.F., Al-Zakwani, I., Panduranga, P., Asaad, N., Shehab, A., AlMahmeed, W. and Al Suwaidi, J. (2020) Clinical Presentation and Outcomes of Peripartum Cardiomyopathy in the Middle East: A Cohort from Seven Arab Countries. ESC Heart Failure, 7, 4134-4138.
https://doi.org/10.1002/ehf2.13030
[6]  Elkayam, U., Tummala, P.P., Rao, K., Akhter, M.W., Karaalp, I.S., Wani, O.R., et al. (2001) Maternal and Fetal Outcomes of Subsequent Pregnancies in Women with Peripartum Cardiomyopathy. The New England Journal of Medicine, 344, 1567-1571.
https://doi.org/10.1002/ehf2.13030
[7]  Siedlecki, P., Kurpesa, M., Uznańska-Loch, B., Trzos, E. and Kasprzak, J.D. (2019) Arrhythmic Manifestation of Peripartum Cardiomyopathy—Case Report. Annals of Noninvasive Electrocardiology, 24, E12551.
https://doi.org/10.1111/anec.12551
[8]  Varagic, J., Desvigne-Nickens, P., Gamble-George, J., Hollier, L., Maric-Bilkan, C., Mitchell, M., Pemberton, V.L. and Redmond, N. (2021) Maternal Morbidity and Mortality: Are We Getting to the “Heart” of the Matter? Journal of Women’s Health (Larchmt), 30, 178-186.
https://doi.org/10.1089/jwh.2020.8852
[9]  Adam, K. (2017) Pregnancy in Women with Cardiovascular Diseases. Methodist DeBakey Cardiovascular Journal, 13, 209-215.
https://doi.org/10.14797/mdcj-13-4-209
[10]  Dawson, A.J., Krastev, Y., Parsonage, W.A., Peek, M., Lust, K. and Sullivan, E.A. (2018) Experiences of Women with Cardiac Disease in Pregnancy: A Systematic Review and Metasynthesis. BMJ Open, 8, E022755.
https://doi.org/10.1136/bmjopen-2018-022755
[11]  Dekker, R.L., Morton, C.H., Singleton, P. and Lyndon, A. (2016) Women’s Experiences Being Diagnosed with Peripartum Cardiomyopathy: A Qualitative Study. Journal of Midwifery & Women’s Health, 61, 467-473.
https://doi.org/10.1111/jmwh.12448
[12]  Ricke-Hoch, M., Pfeffer, T.J. and Hilfiker-Kleiner, D. (2020) Peripartum Cardiomyopathy: Basic Mechanisms and Hope for New Therapies. Cardiovascular Research, 116, 520-531.
https://doi.org/10.1093/cvr/cvz252
[13]  Rodriguez Ziccardi, M. and Siddique, M.S. (2023) Peripartum Cardiomyopathy. StatPearls Publishing, Treasure Island.
https://www.ncbi.nlm.nih.gov/books/nbk482185/
[14]  Biteker, M., Kayatas, K., Duman, D., Turkmen, M. and Bozkurt, B. (2014) Peripartum Cardiomyopathy: Current State of Knowledge, New Developments and Future Directions. Current Cardiology Reviews, 10, 317-326.
https://doi.org/10.2174/1573403X10666140320144048
[15]  Binu, A.J., Rajan, S.J., Rathore, S., Beck, M., Regi, A., Thomson, V.S. and Sathyendra, S. (2020) Peripartum Cardiomyopathy: An Analysis of Clinical Profiles and Outcomes from a Tertiary Care Centre in Southern India. Obstetric Medicine, 13, 179-184.
https://doi.org/10.1177/1753495X19851397
[16]  Koenig, T., Hilfiker-Kleiner, D. and Bauersachs, J. (2018) Peripartum Cardiomyopathy. Herz, 43, 431-437.
https://doi.org/10.1007/s00059-018-4709-z
[17]  Cunningham, M.W. and La Marca, B. (2018) Risk of Cardiovascular Disease, End-Stage Renal Disease, and Stroke in Postpartum Women and Their Fetuses after a Hypertensive Pregnancy. The American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 315, R521-R528.
https://doi.org/10.1152/ajpregu.00218.2017
[18]  Patten, I.S., Rana, S., Shahul, S., Rowe, G.C., Jang, C., Liu, L., Hacker, M.R., Rhee, J.S., Mitchell, J., Mahmood, F., Hess, P., Farrell, C., Koulisis, N., Khankin, E.V., Burke, S.D., Tudorache, I., Bauersachs, J., Del Monte, F., Hilfiker-Kleiner, D., Karumanchi, S.A. and Arany, Z. (2012) Cardiac Angiogenic Imbalance Leads to Peripartum Cardiomyopathy. Nature, 485, 333-338.
https://doi.org/10.1038/nature11040
[19]  Haghikia, A., Podewski, E., Libhaber, E., Labidi, S., Fischer, D., Roentgen, P., Tsikas, D., Jordan, J., Lichtinghagen, R., Von Kaisenberg, C.S., Struman, I., Bovy, N., Sliwa, K., Bauersachs, J. and Hilfiker-Kleiner, D. (2013) Phenotyping and Outcome on Contemporary Management in a German Cohort of Patients with Peripartum Cardiomyopathy. Basic Research in Cardiology, 108, Article No. 366.
https://doi.org/10.1007/s00395-013-0366-9
[20]  Li, A., Campbell, K., Lal, S., Ge, Y., Keogh, A., Macdonald, P.S., Lau, P., Lai, J., Linke, W.A., Van Der Velden, J., Field, A., Martinac, B., Grosser, M. and Dos Remedios, C. (2022) Peripartum Cardiomyopathy: A Global Effort to Find the Cause and Cure for the Rare and Little Understood Disease. Biophysical Reviews, 14, 369-379.
https://doi.org/10.1007/s12551-022-00930-0
[21]  Shimizu, T., Taguchi, A., Higashijima, Y., Kanki, Y., Nakaki, R., Urade, Y. and Wada, Y. (2021) Inhibition of Cardiac PERK Signaling Promotes Peripartum Cardiac Dysfunction. Scientific Reports, 11, Article No. 18687.
https://doi.org/10.1038/s41598-021-98344-7
[22]  Koenig, T., Bauersachs, J. and Hilfiker-Kleiner, D. (2018) Bromocriptine for the Treatment of Peripartum Cardiomyopathy. Cardiac Failure Review, 4, 46-49.
https://doi.org/10.15420/cfr.2018:2:2
[23]  Maynard, S.E., Min, J.Y., Merchan, J., Lim, K.H., Li, J., Mondal, S., Libermann, T.A., Morgan, J.P., Sellke, F.W., Stillman, I.E., Epstein, F.H., Sukhatme, V.P. and Karumanchi, S.A. (2003) Excess Placental Soluble Fms-Like Tyrosine Kinase 1 (SFlt1) May Contribute to Endothelial Dysfunction, Hypertension, and Proteinuria in Preeclampsia. Journal of Clinical Investigation, 111, 649-658.
https://doi.org/10.1172/JCI17189
[24]  Zou, J., Fei, Q., Xiao, H., Wang, H., Liu, K., Liu, M., Zhang, H., Xiao, X., Wang, K. and Wang, N. (2019) VEGF-A Promotes Angiogenesis after Acute Myocardial Infarction through Increasing ROS Production and Enhancing ER Stress-Mediated Autophagy. Journal of Cellular Physiology, 234, 17690-17703.
https://doi.org/10.1002/jcp.28395
[25]  Van Spaendonck-Zwarts, K.Y., Posafalvi, A., Van Den Berg, M.P., Hilfiker-Kleiner, D., Bollen, I.A., Sliwa, K., Alders, M., Almomani, R., Van Langen, I.M., Van Der Meer, P., Sinke, R.J., Van Der Velden, J., Van Veldhuisen, D.J., Van Tintelen, J.P. and Jongbloed, J.D. (2014) Titin Gene Mutations Are Common in Families with both Peripartum Cardiomyopathy and Dilated Cardiomyopathy. European Heart Journal, 35, 2165-2173.
https://doi.org/10.1093/eurheartj/ehu050
[26]  Petrakos, G., Andriopoulos, P. and Tsironi, M. (2016) Pregnancy in Women with Thalassemia: Challenges and Solutions. International Journal of Women’s Health, 8, 441-451.
https://doi.org/10.2147/IJWH.S89308
[27]  Hoes, M.F., Arany, Z., Bauersachs, J., Hilfiker-Kleiner, D., Petrie, M.C., Sliwa, K. and Van Der Meer, P. (2022) Pathophysiology and Risk Factors of Peripartum Cardiomyopathy. Nature Reviews Cardiology, 19, 555-565.
https://doi.org/10.1038/s41569-021-00664-8
[28]  (2004) Abstracts of the 27th Annual Meeting of the Society of General Internal Medicine. Chicago, Illinois, USA, 12-15 May, 2004. Journal of General Internal Medicine, 19, 23-260.
[29]  Negi, S., Sawano, M., Kohsaka, S., Inohara, T., Shiraishi, Y., Kohno, T., Maekawa, Y., Sano, M., Yoshikawa, T. and Fukuda, K. (2014) Prognostic Implication of Physical Signs of Congestion in Acute Heart Failure Patients and Its Association with Steady-State Biomarker Levels. PLOS ONE, 9, E96325.
https://doi.org/10.1371/journal.pone.0096325
[30]  Cao, Z., Jia, Y. and Zhu, B. (2019) BNP and NT-ProBNP as Diagnostic Biomarkers for Cardiac Dysfunction in both Clinical and Forensic Medicine. International Journal of Molecular Sciences, 20, Article No. 1820.
https://doi.org/10.3390/ijms20081820
[31]  Gregoric, I.D., Poredos, P., Jezovnik, M.K., Ilic, M., Shoukat, S., Radovancevic, R., Sharma, T., Akay, M.H., Matejin, S., Nathan, S., Patel, M. and Kar, B. (2021) Use of Transthoracic Echocardiogram to Detect Left Ventricular Thrombi. The Annals of Thoracic Surgery, 111, 556-560.
https://doi.org/10.1016/j.athoracsur.2020.05.106
[32]  West, A.M. and Kramer, C.M. (2010) Cardiovascular Magnetic Resonance Imaging of Myocardial Infarction, Viability, and Cardiomyopathies. Current Problems in Cardiology, 35, 176-220.
https://doi.org/10.1016/j.cpcardiol.2009.12.002
[33]  Bauersachs, J., König, T., Van Der Meer, P., Petrie, M.C., Hilfiker-Kleiner, D., Mbakwem, A., Hamdan, R., Jackson, A.M., Forsyth, P., De Boer, R.A., Mueller, C., Lyon, A.R., Lund, L.H., Piepoli, M.F., Heymans, S., Chioncel, O., Anker, S.D., Ponikowski, P., Seferovic, P.M., Johnson, M.R., Mebazaa, A. and Sliwa, K. (2019) Pathophysiology, Diagnosis and Management of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy. European Journal of Heart Failure, 21, 827-843.
https://doi.org/10.1002/ejhf.1493
[34]  Ural, D., Çavuşoğlu, Y., Eren, M., Karaüzüm, K., Temizhan, A., Yılmaz, M.B., Zoghi, M., Ramassubu, K. and Bozkurt, B. (2015) Diagnosis and Management of Acute Heart Failure. The Anatolian Journal of Cardiology, 15, 860-889.
https://doi.org/10.5152/AnatolJCardiol.2015.6567
[35]  Chioncel, O., Collins, S.P., Ambrosy, A.P., Pang, P.S., Radu, R.I., Antohi, E.L., Masip, J., Butler, J. and Iliescu, V.A. (2019) Therapeutic Advances in the Management of Cardiogenic Shock. American Journal of Therapeutics, 26, E234-E247.
https://doi.org/10.1097/MJT.0000000000000920
[36]  Tamirisa, K.P., Dye, C., Bond, R.M., Hollier, L.M., Marinescu, K., Vaseghi, M., Russo, A.M., Gulati, M. and Volgman, A.S. (2022) Arrhythmias and Heart Failure in Pregnancy: A Dialogue on Multidisciplinary Collaboration. Journal of Cardiovascular Development and Disease, 9, Article No. 199.
https://doi.org/10.3390/jcdd9070199
[37]  Martin, N., Manoharan, K., Thomas, J., Davies, C. and Lumbers, R.T. (2018) Beta-Blockers and Inhibitors of the Renin-Angiotensin Aldosterone System for Chronic Heart Failure with Preserved Ejection Fraction. Cochrane Database of Systematic Reviews, 6, CD012721.
https://doi.org/10.1002/14651858.CD012721.pub2
[38]  Arany, Z. and Feldman, A.M. (2019) to Breastfeed or Not to Breastfeed with Peripartum Cardiomyopathy. JACC: Basic to Translational Science, 4, 301-303.
https://doi.org/10.1016/j.jacbts.2019.03.005
[39]  Rose, E.A., Gelijns, A.C., Moskowitz, A.J., Heitjan, D.F., Stevenson, L.W., Dembitsky, W., Long, J.W., Ascheim, D.D., Tierney, A.R., Levitan, R.G., Watson, J.T., Meier, P., Ronan, N.S., Shapiro, P.A., Lazar, R.M., Miller, L.W., Gupta, L., Frazier, O.H., Desvigne-Nickens, P., Oz, M.C., Poirier, V.L. and Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group (2001) Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure. The New England Journal of Medicine, 345, 1435-1443.
https://doi.org/10.1056/NEJMoa012175
[40]  Azibani, F. and Sliwa, K. (2018) Peripartum Cardiomyopathy: An Update. Current Heart Failure Reports, 15, 297-306.
https://doi.org/10.1007/s11897-018-0404-x
[41]  Hoevelmann, J., Hähnle, L., Hähnle, J., Sliwa, K. and Viljoen, C. (2020) Detection and Management of Arrhythmias in Peripartum Cardiomyopathy. Cardiovascular Diagnosis and Therapy, 10, 325-335.
https://doi.org/10.21037/cdt.2019.05.03
[42]  Rosenkaimer, S.L., El-Battrawy, I., Dreher, T.C., Gerhards, S., Röger, S., Kuschyk, J., Borggrefe, M. and Akin, I. (2020) The Wearable Cardioverter-Defibrillator: Experience in 153 Patients and a Long-Term Follow-Up. Journal of Clinical Medicine, 9, Article No. 893.
https://doi.org/10.3390/jcm9030893
[43]  Al Habeeb, W., Tash, A., Elasfar, A., Almasood, A., Bakhsh, A., Elshaer, F., Al Ayoubi, F., AIghalayini, K.W., Al Qaseer, M.M., Alhussein, M., Almogbel, O., Al Saif, S.M. and Al Hebeshi, Y. (2023) 2023 National Heart Center/Saudi Heart Association Focused Update of the 2019 Saudi Heart Association Guidelines for the Management of Heart Failure. Journal of the Saudi Heart Association, 35, 71-134.
https://doi.org/10.37616/2212-5043.1334
[44]  Sedlak, T., Bairey Merz, C.N., Shufelt, C., Gregory, K.D. and Hamilton, M.A. (2012) Contraception in Patients with Heart Failure. Circulation, 126, 1396-1400.
https://doi.org/10.1161/CIRCULATIONAHA.111.070607
[45]  Okeke, T., Ezenyeaku, C. and Ikeako, L. (2013) Peripartum Cardiomyopathy. Annals of Medical and Health Science Research, 3, 313-319.
https://doi.org/10.4103/2141-9248.117925
[46]  Sliwa, K., Blauwet, L., Tibazarwa, K., Libhaber, E., Smedema, J.P., Becker, A., McMurray, J., Yamac, H., Labidi, S., Struman, I. and Hilfiker-Kleiner, D. (2010) Evaluation of Bromocriptine in the Treatment of Acute Severe Peripartum Cardiomyopathy: A Proof-of-Concept Pilot Study. Circulation, 121, 1465-1473.
https://doi.org/10.1161/CIRCULATIONAHA.109.901496
[47]  Wang, M. (2009) Peripartum Cardiomyopathy: Case Reports. The Permanente Journal, 13, 42-45.
https://doi.org/10.7812/TPP/08-079
[48]  Kotchetkov, R., Patel, A. and Salehian, O. (2010) Ventricular Tachycardia in Pregnant Patients. Clinical Medicine Insights: Cardiology, 4, 39-44.
https://doi.org/10.4137/CMC.S4755
[49]  Soar, J. (2018) Antiarrhythmic Drug Therapy during Cardiopulmonary Resuscitation: Should We Use It? Current Opinion in Critical Care, 24, 138-142.
https://doi.org/10.1097/MCC.0000000000000498
[50]  Carlson, S., Schultz, J., Ramu, B. and Davis, M.B. (2023) Peripartum Cardiomyopathy: Risks Diagnosis and Management. Journal of Multidisciplinary Healthcare, 16, 1249-1258.
https://doi.org/10.2147/JMDH.S372747
[51]  Diao, M., Diop, I.B., Kane, A., et al. (2004) Electrocardiographic Recording of Long Duration (Holter) of 24 Hours during Idiopathic Cardiomyopathy of the Peripartum. Archives des Maladies du Coeur et des Vaisseaux, 97, 25-30.
[52]  Laghari, A.H., Khan, A.H. and Kazmi, K.A. (2013) Peripartum Cardiomyopathy: Ten Year Experience at a Tertiary Care Hospital in Pakistan. BMC Research Notes, 6, Article No. 495.
https://doi.org/10.1186/1756-0500-6-495
[53]  Mallikethi-Reddy, S., Akintoye, E., Trehan, N., Sharma, S., Briasoulis, A., Jagadeesh, K., Rubenfire, M., Grines, C.L. and Afonso, L. (2017) Burden of Arrhythmias in Peripartum Cardiomyopathy: Analysis of 9841 Hospitalizations. International Journal of Cardiology, 235, 114-117.
https://doi.org/10.1016/j.ijcard.2017.02.084
[54]  Honigberg, M.C. and Givertz, M.M. (2015) Arrhythmias in Peripartum Cardiomyopathy. Cardiac Electrophysiology Clinics, 7, 309-317.
https://doi.org/10.1016/j.ccep.2015.03.010

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413